Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DNA
Research
Rome's 'dark genome' drug reduces autoimmune markers in mice
Preclinical tests of Rome Therapeutics' drug show that it’s effective in reducing a type of inflammation believed to promote autoimmune disease.
Helen Floersh
Nov 17, 2023 1:03pm
Inovio drafts accelerated approval talking points for FDA visit
Nov 10, 2023 7:28am
Inovio says no-go on phase 3 program, lays off 30% of staff
Aug 10, 2023 8:00am
Don't junk DNA as study shows new role in brain disease
Sep 30, 2022 3:25pm
Pfizer, BMS vet hits Replay with $55M seed financing
Jul 25, 2022 11:24am
CHOP researchers pinpoint genetic variant associated with bacterial ear infection in children
Oct 5, 2016 4:26am